This paper, published in the journal Vaccine, investigates whether routine infant immunization with either currently licensed rotavirus vaccine could be cost-effective in Taiwan. The authors modeled specific disease outcomes including hospitalization, emergency department visits, hospital outpatient visits, physician office visits, and death. Cost-effectiveness was analyzed from the perspectives of the health care system and society.

Author(s): Wu CL, Yang YC, Huang LM, Chen KT

Published: 2009

Resource types: Peer-reviewed journal

Diseases: Rotavirus

Topics: Immunization financing; Disease burden and surveillance; Disease/vaccine specific information

Regions: Asia